Results 81 to 90 of about 10,977 (244)

Evolution of clinical ideas about Zollinger-Ellison syndrome

Терапевтический архив, 2014
The paper gives the current views of the diagnosis and treatment of Zollinger-Ellison syndrome (ZES). It underlines the importance of including ZES in differential diagnosis in patient with frequently recurrent and standard-dose proton pump inhibitor ...
I V Maev, D N Andreev, Iu A Kucheriavyĭ, E V Barkalova   +3 more
doaj  

Tumor carcinóide de estômago tipo 1

Revista do Colégio Brasileiro de Cirurgiões
Gastric carcinoid occurs in less than 1% of gastric neoplasias and around 2% of carcinoids tumors. They are classified into three forms: type 1, associated with atrophic gastritis, type 2, associated with multiple endocrine neoplasia 1 and Zollinger ...
Rubens Valarini, Eliziane Hoeldtke, Nertan Luiz Tefilli   +2 more
doaj   +1 more source

Multiple endocrine neoplasia [PDF]

, 2017
Multiple endocrine neoplasia (MEN) describes the occurrence of tumours affecting two or more endocrine glands in one patient. Two main forms are recognized: MEN type 1 (MEN1) and type 2 (MEN2).
Newey, Paul J.
core   +2 more sources

Association of Omeprazole‐Related Myopathy With Drug–Drug and Drug–Gene Interactions Involving CYP2C19 and CYP3A4: A Nested Case–Control Study

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 45, Issue 10, Page 654-666, October 2025.
ABSTRACT Background Omeprazole, a widely used proton pump inhibitor, has been associated with rare but serious adverse events such as myopathy. Previous research suggests that concurrent use of omeprazole with fluconazole, a potent cytochrome P450 (CYP) 2C19/3A4 inhibitor, may increase the risk of myopathy.
Eugene Jeong, Aditi Shendre, Yu Su, Xingyi Guo, Lang Li, You Chen   +5 more
wiley   +1 more source

Step‐by‐Step Approach to the Incidental Diagnosis of Type I Gastric Neuroendocrine Tumors: Practical Insights

JGH Open, Volume 9, Issue 9, September 2025.
ABSTRACT Objective The incidental diagnosis of type I gastric neuroendocrine tumors (gNETs) has become increasingly frequent in clinical practice, largely due to the widespread use of upper gastrointestinal endoscopy and improved recognition of these lesions.
Laura Baldini, Elisabetta Dell'Unto, Maria Rinzivillo, Gianluca Esposito, Francesco Panzuto   +4 more
wiley   +1 more source

Zollinger–Ellison syndrome: modern aspects of diagnostics and treatment

Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2014
The aim of review. To reflect modern concepts on clinic, diagnostics and treatment of Zollinger–Ellison syndrome (ZES).Key points. ZES is rare disease related to intragastric hyperacidity.
I. V. Mayev, D. N. Andreev, Yu. A. Kucheryavyy, D. T. Dicheva   +3 more
doaj  

Differences in Endoscopic Features of Gastric Neuroendocrine Tumor and Neuroendocrine Carcinoma From a Clinicopathological Perspective

JGH Open, Volume 9, Issue 9, September 2025.
ABSTRACT Gastric neuroendocrine neoplasms are a rare type of stomach cancer, classified into well‐differentiated neuroendocrine tumors (NETs) and poorly differentiated neuroendocrine carcinomas (NECs). Gastric NETs (G‐NETs) originate from endocrine progenitor cells in the basal layer of the mucosa, primarily in the setting of chronic atrophic gastritis,
Katsunori Matsueda, Noriya Uedo, Masanori Kitamura, Seiji Kawano, Motoyuki Otsuka   +4 more
wiley   +1 more source

Cholecystokinin: Clinical aspects of the new biology

Journal of Internal Medicine, Volume 298, Issue 3, Page 251-267, September 2025.
Abstract Cholecystokinin (CCK) is a classic gut hormone that has been known for almost a century to regulate gallbladder emptying, pancreatic enzyme secretion, and gastrointestinal motor activity. In 1968, the CCK structure was identified by Viktor Mutt and Erik Jorpes from porcine gut extracts as a peptide of 33 amino acid residues.
Jens F. Rehfeld
wiley   +1 more source

Considerations concerning a tailored, individualized therapeutic management of patients with (neuro)endocrine tumours of the gastrointestinal tract a [PDF]

, 2004
Endocrine tumours of the gastrointestinal tract and pancreas may present at different disease stages with either hormonal or hormone-related symptoms/syndromes, or without hormonal symptoms. They may occur either sporadically or as part
Eijck, C.H.J. (Casper) van, Herder, W.W. (Wouter) de, Krenning, E.P. (Eric), Lamberts, S.W.J. (Steven)   +3 more
core  

Proton pump inhibitors: are they overutilised in clinical practice and do they pose significant risk? [PDF]

, 2012
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/92027/1/j.1742-1241.2012.02921.x ...
American Society of Health-System Pharmacists, Aseeri, Batuwitage, Bhatt, Cash, Chiu, Conrad, Corley, de, DeVault, Dial, Dial, Dial, Fendrick, Forgacs, Gilard, Gillen, Gillen, Gray, Gulmez, Heidelbaugh, Heidelbaugh, Heidelbaugh, Howden, Hunfeld, Inadomi, Inadomi, Inadomi, Jacobson, Jayatilaka, Kahrilas, Kahrilas, Kaye, Klinkenberg-Knol, Klinkenberg-Knol, Laheij, Leonard, Mat Saad, Metz, Metz, Metz, Metz, Metz, Nardino, Naunton, Niklasson, Pisegna, Pouwels, Ray, Reimer, Robertson, Sachs, Sarkar, Scheiman, Schubert, Shi, Shin, Siller-Matula, Small, Targownik, Targownik, Van Soest, Vestergaard, Waldum, Yang, Yang, Yang, Yearsley, Zink   +68 more
core   +1 more source